Shackley, P.; Shaw, L.; Price, C.; Wijck, F.V.; Barnes, M.; Graham, L.; Ford, G.A.; Steen, N.; Rodgers, H.
Cost-Effectiveness of Treating Upper Limb Spasticity Due to Stroke with Botulinum Toxin Type A: Results from the Botulinum Toxin for the Upper Limb after Stroke (BoTULS) Trial. Toxins 2012, 4, 1415-1426.
https://doi.org/10.3390/toxins4121415
AMA Style
Shackley P, Shaw L, Price C, Wijck FV, Barnes M, Graham L, Ford GA, Steen N, Rodgers H.
Cost-Effectiveness of Treating Upper Limb Spasticity Due to Stroke with Botulinum Toxin Type A: Results from the Botulinum Toxin for the Upper Limb after Stroke (BoTULS) Trial. Toxins. 2012; 4(12):1415-1426.
https://doi.org/10.3390/toxins4121415
Chicago/Turabian Style
Shackley, Phil, Lisa Shaw, Christopher Price, Frederike Van Wijck, Michael Barnes, Laura Graham, Gary A. Ford, Nick Steen, and Helen Rodgers.
2012. "Cost-Effectiveness of Treating Upper Limb Spasticity Due to Stroke with Botulinum Toxin Type A: Results from the Botulinum Toxin for the Upper Limb after Stroke (BoTULS) Trial" Toxins 4, no. 12: 1415-1426.
https://doi.org/10.3390/toxins4121415
APA Style
Shackley, P., Shaw, L., Price, C., Wijck, F. V., Barnes, M., Graham, L., Ford, G. A., Steen, N., & Rodgers, H.
(2012). Cost-Effectiveness of Treating Upper Limb Spasticity Due to Stroke with Botulinum Toxin Type A: Results from the Botulinum Toxin for the Upper Limb after Stroke (BoTULS) Trial. Toxins, 4(12), 1415-1426.
https://doi.org/10.3390/toxins4121415
